4.6 Article

A poly-neoantigen DNA vaccine synergizes with PD-1 blockade to induce T cell-mediated tumor control

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

Personalized neoantigen vaccines: A new approach to cancer immunotherapy

Amanda R. Aldous et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2018)

Article Chemistry, Multidisciplinary

Cationic Liposomes: A Flexible Vaccine Delivery System for Physicochemically Diverse Antigenic Peptides

Jeroen Heuts et al.

PHARMACEUTICAL RESEARCH (2018)

Article Medicine, Research & Experimental

MERTK inhibition alters the PD-1 axis and promotes anti-leukemia immunity

Alisa B. Lee-Sherick et al.

JCI INSIGHT (2018)

Review Immunology

CD4+ T cell help in cancer immunology and immunotherapy

Jannie Borst et al.

NATURE REVIEWS IMMUNOLOGY (2018)

Article Multidisciplinary Sciences

An immunogenic personal neoantigen vaccine for patients with melanoma

Patrick A. Ott et al.

NATURE (2017)

Article Oncology

PD-L1 expression on malignant cells is no prerequisite for checkpoint therapy

Jan Willem Kleinovink et al.

ONCOIMMUNOLOGY (2017)

Article Immunology

A cGAS-Independent STING/IRF7 Pathway Mediates the Immunogenicity of DNA Vaccines

John J. Suschak et al.

JOURNAL OF IMMUNOLOGY (2016)

Article Multidisciplinary Sciences

Mutant MHC class II epitopes drive therapeutic immune responses to cancer

Sebastian Kreiter et al.

NATURE (2015)

Article Oncology

Exploiting the Mutanome for Tumor Vaccination

John C. Castle et al.

CANCER RESEARCH (2012)

Review Biotechnology & Applied Microbiology

DNA Vaccines: Developing New Strategies against Cancer

Daniela Fioretti et al.

JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2010)

Article Immunology

Naive tumor-specific CD4+ T cells differentiated in vivo eradicate established melanoma

Ying Xie et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2010)

Article Oncology

Induction of T cell-mediated immunity using a c-Myb DNA vaccine in a mouse model of colon cancer

Benjamin B. Williams et al.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)

Article Hematology

CD4 cells can be more efficient at tumor rejection than CD8 cells

Ainhoa Perez-Diez et al.

Review Medicine, Research & Experimental

Immune surveillance of tumors

Jeremy B. Swann et al.

JOURNAL OF CLINICAL INVESTIGATION (2007)

Article Biochemistry & Molecular Biology

A rapid and potent DNA vaccination strategy defined by in vivo monitoring of antigen expression

AD Bins et al.

NATURE MEDICINE (2005)

Article Oncology

CD4+T cell-mediated HER-2/neu-specific tumor rejection in the absence of B cells

JA Lindencrona et al.

INTERNATIONAL JOURNAL OF CANCER (2004)